AT348154B - Verfahren zur herstellung von neuen, optisch aktiven oder racemischen 3beta-hydroxy-2- (subst. 1-alkenyl)-5-oxocyclopentan-1- heptansaeuren - Google Patents

Verfahren zur herstellung von neuen, optisch aktiven oder racemischen 3beta-hydroxy-2- (subst. 1-alkenyl)-5-oxocyclopentan-1- heptansaeuren

Info

Publication number
AT348154B
AT348154B AT261475A AT261475A AT348154B AT 348154 B AT348154 B AT 348154B AT 261475 A AT261475 A AT 261475A AT 261475 A AT261475 A AT 261475A AT 348154 B AT348154 B AT 348154B
Authority
AT
Austria
Prior art keywords
oxocyclopentan
heptanic
3beta
subst
racemic
Prior art date
Application number
AT261475A
Other languages
German (de)
English (en)
Other versions
ATA261475A (de
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ATA261475A publication Critical patent/ATA261475A/de
Application granted granted Critical
Publication of AT348154B publication Critical patent/AT348154B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
AT261475A 1974-04-08 1975-04-07 Verfahren zur herstellung von neuen, optisch aktiven oder racemischen 3beta-hydroxy-2- (subst. 1-alkenyl)-5-oxocyclopentan-1- heptansaeuren AT348154B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45879974A 1974-04-08 1974-04-08

Publications (2)

Publication Number Publication Date
ATA261475A ATA261475A (de) 1978-06-15
AT348154B true AT348154B (de) 1979-02-12

Family

ID=23822127

Family Applications (1)

Application Number Title Priority Date Filing Date
AT261475A AT348154B (de) 1974-04-08 1975-04-07 Verfahren zur herstellung von neuen, optisch aktiven oder racemischen 3beta-hydroxy-2- (subst. 1-alkenyl)-5-oxocyclopentan-1- heptansaeuren

Country Status (14)

Country Link
JP (1) JPS5835183B2 (sv)
AT (1) AT348154B (sv)
BE (1) BE827694A (sv)
CA (1) CA1071625A (sv)
CH (1) CH609971A5 (sv)
DE (1) DE2515115A1 (sv)
DK (1) DK147075A (sv)
ES (1) ES436362A1 (sv)
FR (1) FR2266500B1 (sv)
GB (1) GB1496716A (sv)
IE (1) IE41470B1 (sv)
NL (1) NL7504104A (sv)
SE (1) SE420998B (sv)
ZA (1) ZA752183B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60102774U (ja) * 1983-12-14 1985-07-13 ソニー株式会社 フロツピ−デイスクカセツト
JPS60106272U (ja) * 1983-12-24 1985-07-19 ソニー株式会社 フロツピ−デイスクカセツト
JPS60106271U (ja) * 1983-12-24 1985-07-19 ソニー株式会社 フロツピ−デイスクカセツト
JPS60140266U (ja) * 1984-02-25 1985-09-17 ソニー株式会社 磁気デイスク装置
JPS6121075U (ja) * 1984-07-07 1986-02-06 ティーディーケイ株式会社 デイスクカ−トリツジ

Also Published As

Publication number Publication date
NL7504104A (nl) 1975-10-10
IE41470L (en) 1975-10-08
CH609971A5 (en) 1979-03-30
DK147075A (sv) 1975-10-09
SE7503928L (sv) 1975-10-09
FR2266500A1 (sv) 1975-10-31
BE827694A (fr) 1975-10-08
JPS5835183B2 (ja) 1983-08-01
GB1496716A (en) 1977-12-30
IE41470B1 (en) 1980-01-16
FR2266500B1 (sv) 1978-07-28
SE420998B (sv) 1981-11-16
ATA261475A (de) 1978-06-15
AU7990675A (en) 1976-10-14
ZA752183B (en) 1976-06-30
ES436362A1 (es) 1977-01-01
DE2515115A1 (de) 1975-10-16
JPS50137960A (sv) 1975-11-01
CA1071625A (en) 1980-02-12

Similar Documents

Publication Publication Date Title
AT351684B (de) Verfahren zur herstellung von neuen optisch aktiven oder racemischen verbindungen
AT360974B (de) Verfahren zur herstellung von neuen optisch aktiven oder racemischen aniliden
AT366030B (de) Verfahren zur herstellung von neuen carboxyalkylacylaminosaeuren, bzw. deren estern undihren salzen
AT342026B (de) Verfahren zur herstellung von neuen d,l-n-acyltyrosinamiden
AT360182B (de) Verfahren zur herstellung von neuen, optisch aktiven und racemischen prostaglandin-derivaten
AT342045B (de) Verfahren zur herstellung von neuen 1,1-diaryl-1-oxadiazolalkylaminen
AT343631B (de) Verfahren zur herstellung von racemischem und optisch aktivem threo- und erythro-3-(3,4-dihydroxyphenyl)-serin
AT360673B (de) Verfahren zur herstellung von neuen optisch aktiven 11-desoxy-16-aryl-omega-prostaglandinen
AT350043B (de) Verfahren zur herstellung von neuen 3-polyhalogenaethyl-2, 2-dimethylcyclopropan- carbonsaeuren
AT360509B (de) Verfahren zur herstellung von neuen racemischen oder optisch aktiven aminosaeuren
AT348154B (de) Verfahren zur herstellung von neuen, optisch aktiven oder racemischen 3beta-hydroxy-2- (subst. 1-alkenyl)-5-oxocyclopentan-1- heptansaeuren
AT341540B (de) Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen
AT359214B (de) Verfahren zur herstellung von neuen 9- -hydroxy-19,20-dinorprostanoesaeuren
AT355556B (de) Verfahren zur herstellung von neuen racemischen oder optisch aktiven threo- oder erythro-1- phenyl-2-n-alkylamino-propandiol-1,3-derivaten
CH552034A (de) Verfahren zur herstellung von neuen azopigmenten.
AT325599B (de) Verfahren zur herstellung von neuen, racemischen oder optisch aktiven furanderivaten
AT326841B (de) Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-pregnenen
AT341669B (de) Verfahren zur herstellung von neuen 3,4-dicarboxycephalosporinen
AT346505B (de) Verfahren zur herstellung von neuem racemischem 13beta-aethyl-3-methoxy-8,14-seco- gona-1,3,5 (10), 8-tetraen-17beta-ol-14-on
AT332537B (de) Verfahren zur herstellung von 6beta-amino-2,2-dimethylpenam-3alfa-carbonsaure
ATA423876A (de) Verfahren zur herstellung von neuen, racemischen oder optisch aktiven morphinan- derivaten
ATA196973A (de) Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbon
AT316520B (de) Verfahren zur Herstellung von neuen racemischen bzw. optisch aktiven 6-Hydroxy-6-(3-alkoxy- oder - cycloalkoxy-phenyl)-hexan-3-onen
ATA491379A (de) Verfahren zur herstellung von neuen 2,9alpha-
AT333254B (de) Verfahren zur herstellung von neuen racemischen und optisch aktiven aminophenyl-athanolaminen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee